ACLY and esophageal squamous cell carcinoma: To explore the effect of the ACLY inhibitor BMS‐303141 on the growth of xenograft tumours in nude mice, we established subcutaneous tumour model using human ESCC cells KYSE150, and then BMS‐303141 was used to treat the tumour.